In June 2005 the FDA withdrew approval for use in new patients due to lack of evidence that it extended life.
NgoJuni 2005 i-FDA yahoxisa imvume yokusetshenziswa ezigulini ezintsha ngenxa yokushoda kobufakazi bokuthi yelula impilo.